TL;DR
This study identifies a novel regulatory axis, miR-874-3p targeting ATF3, that plays a protective role in intervertebral disc degeneration (IVDD). By using single-cell RNA sequencing and various validation techniques, the researchers found that this axis can inhibit key pathological processes in IVDD, including ferroptosis, apoptosis, and inflammation, suggesting it as a potential therapeutic target.
What Problem Does This Paper Address?
Intervertebral disc degeneration (IVDD) is a widespread condition that significantly impacts quality of life, leading to various spinal disorders and chronic pain. While previous research has implicated the transcription factor ATF3 in blocking IVDD's pathological processes by influencing cell death, inflammation, and extracellular matrix (ECM) metabolism, the upstream regulators of ATF3 in this context remained unclear. Specifically, the role of miR-874-3p, a microRNA previously found to be downregulated in IVDD, in mediating IVDD pathology through ATF3 was not well understood. This paper aims to elucidate this relationship and explore its therapeutic potential.
Methods
The researchers employed a multi-pronged approach:
- Single-cell RNA sequencing (scRNA-seq): This was the cornerstone technique used to identify ATF3 as a key ferroptosis gene in IVDD and to analyze its expression patterns across different cell types in degenerated intervertebral discs.
- Bioinformatics Analysis: This included Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses to understand the biological functions associated with ATF3. Protein-protein interaction (PPI) network analysis was used to identify hub genes.
- Molecular Biology Techniques:
- Western Blotting: Used to detect and quantify protein expression levels of ATF3 and other key molecules involved in apoptosis, ferroptosis, and ECM metabolism.
- Flow Cytometry: Employed to measure NPC apoptosis.
- Enzyme-Linked Immunosorbent Assay (ELISA): Used to quantify levels of pro-inflammatory cytokines (TNF-α, IL-6, IL-1β).
- Dual-Luciferase Reporter Gene Experiment: Performed to confirm the direct binding of miR-874-3p to the 3'-UTR of ATF3.
- Animal Models: An IVDD rat model was established to validate the in vivo effects of miR-874-3p and its axis on IVDD progression.
Datasets
- Human IVDD Patient Data: Used for initial validation of ATF3 expression.
- Rat Intervertebral Disc Tissues: Collected from a surgically induced IVDD model for scRNA-seq analysis.
- GSE154619 Dataset: A publicly available dataset used for comparative analysis of gene expression.
Key Insights and Ideas
- ATF3 as a Central Player: The study strongly implicates ATF3 not only in IVDD pathology but also specifically as a key ferroptosis gene. Its high expression across multiple cell types in degenerated discs highlights its broad involvement.
- miR-874-3p as a Regulator: The research provides compelling evidence that miR-874-3p directly targets and inhibits ATF3. This establishes a clear regulatory link between the microRNA and the transcription factor.
- Multifaceted Protective Role: The miR-874-3p/ATF3 axis demonstrates a protective effect by simultaneously mitigating ferroptosis, apoptosis, ECM degradation, and inflammatory responses – the core pathological hallmarks of IVDD.
- Therapeutic Potential: The findings suggest that both miR-874-3p and ATF3 could serve as valuable biomarkers for IVDD diagnosis and prognosis, and importantly, that targeting the miR-874-3p/ATF3 axis offers a promising therapeutic avenue.
Key Results
- ATF3 Upregulation: ATF3 was found to be significantly upregulated in IVDD patients and in multiple cell types (chondrocytes, ECM-secreting cells, inflammatory response cells, and proliferating cells) of degenerated rat intervertebral discs, as confirmed by scRNA-seq.
- miR-874-3p Targets ATF3: Dual-luciferase reporter assays confirmed that miR-874-3p directly binds to the 3'-UTR of ATF3, inhibiting its activity.
- Inhibition of Pathological Processes: Overexpression of miR-874-3p (or knockdown of ATF3) significantly inhibited NPC apoptosis, ferroptosis (indicated by increased GPX4 and SLC7A11 expression), and ECM degradation (indicated by reduced MMP2/3 and increased Aggrecan/COL2A1 expression). It also reduced pro-inflammatory cytokine levels (TNF-α, IL-6, IL-1β) and reactive oxygen species (ROS).
- In Vivo Efficacy: In a rat IVDD model, miR-874-3p mimic treatment led to reduced ATF3 expression and increased GPX4 expression, along with inhibited NPC apoptosis, supporting its protective role in vivo.
Limitations and Future Work
The authors acknowledge several limitations:
- Human vs. Rat Tissues: While scRNA-seq was performed on rat tail discs, human IVDD data was primarily from literature searches. Future work should involve direct scRNA-seq on human NP tissues.
- Sample Size: The study used only one normal and one degenerated intervertebral disc tissue for sequencing, which may limit the accuracy of the results. Larger sample sizes are recommended for future validation.
- Imaging and Histology: While animal experiments were conducted, further imaging and histological evaluation methods are suggested to more comprehensively demonstrate the regulatory effects of the miR-874-3p/ATF3 axis.
- Cell Sorting: The authors suggest that fluorescence-activated cell sorting (FACS) could be used to isolate specific chondrocyte clusters for more targeted validation of miR-874-3p/ATF3 signaling.
Summary updated